9/27/2018 11:46:40 AM - Rebounding near its 50 DMA line ($14.18) which may act as resistance. Reported earnings +41% on +12% sales revenues for the Apr '18 quarter. Noted following M&A news in the 5/21/18 mid-day report - "Quarterly comparisons through Jan '18 have shown strong sales revenues and earnings increases above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw with regard to the strict guidelines of the fact-based investment system."

9/25/2018 1:20:22 PM - Slumped below its 50 DMA line in recent weeks. Reported earnings +41% on +12% sales revenues for the Apr '18 quarter. Last noted following M&A news in the 5/21/18 mid-day report - "Quarterly comparisons through Jan '18 have shown strong sales revenues and earnings increases above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw with regard to the strict guidelines of the fact-based investment system."

5/21/2018 12:56:40 PM - Perched at its 52-week high following M&A news on 5/08/18. Made gradual progress since noted with caution in the 3/21/18 mid-day report - "Quarterly comparisons through Jan '18 have shown strong sales revenues and earnings increases above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw with regard to the strict guidelines of the fact-based investment system."

5/10/2018 1:26:14 PM - Perched at its 52-week high following M&A news on 5/08/18. Made gradual progress since noted with caution in the 3/21/18 mid-day report - "Quarterly comparisons through Jan '18 have shown strong sales revenues and earnings increases above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw with regard to the strict guidelines of the fact-based investment system."

5/9/2018 1:39:47 PM - Perched at its 52-week high following M&A news on 5/08/18. Made gradual progress since noted with caution in the 3/21/18 mid-day report - "Quarterly comparisons through Jan '18 have shown strong sales revenues and earnings increases above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw with regard to the strict guidelines of the fact-based investment system."

5/8/2018 1:15:45 PM - Today's gain has it getting more extended from prior highs in the $10 area. Made gradual progress since last noted with caution in the 3/21/18 mid-day report - "Quarterly comparisons through Jan '18 have shown strong sales revenues and earnings increases above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw with regard to the strict guidelines of the fact-based investment system."

3/21/2018 1:23:17 PM - Extended from prior highs in the $10 area after an impressive steak of gains in recent weeks. Quarterly comparisons through Jan '18 have shown strong sales revenues and earnings increases above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw with regard to the strict guidelines of the fact-based investment system.